Literature DB >> 3301658

Current concepts in the management of thalassemia.

R S Festa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3301658     DOI： 10.1007/BF02748923

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN： 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  37 in total

1.  Activated oxygen and haemolysis.

Authors:  R W Carrell; C C Winterbourn; E A Rachmilewitz
Journal:  Br J Haematol       Date:  1975-07       Impact factor: 6.998

2.  Continuous subcutaenous administration of deferoxamine in patients with iron overload.

Authors:  R D Propper; B Cooper; R R Rufo; A W Nienhuis; W F Anderson; H F Bunn; A Rosenthal; D G Nathan
Journal:  N Engl J Med       Date:  1977-08-25       Impact factor: 91.245

3.  Ascorbic acid enhancement of desferrioxamine-induced urinary iron excretion in thalassemia major.

Authors:  R T O'Brien
Journal:  Ann N Y Acad Sci       Date:  1974       Impact factor: 5.691

4.  Growth of children with thalassaemia: effect of different transfusion regimens.

Authors:  C Kattamis; N Touliatos; S Haidas; N Matsaniotis
Journal:  Arch Dis Child       Date:  1970-08       Impact factor: 3.791

5.  Chelation regimens with desferrioxamine.

Authors:  M J Pippard; S T Callender; D J Weatherall
Journal:  Lancet       Date:  1977-05-21       Impact factor: 79.321

Review 6.  Marrow transplantation for congenital disorders.

Authors:  R J O'Reilly; J Brochstein; R Dinsmore; D Kirkpatrick
Journal:  Semin Hematol       Date:  1984-07       Impact factor: 3.851

7.  Haemoglobin levels and blood requirement in thalassaemia.

Authors:  V Gabutti; A Piga; P Nicola; C Vullo; L Capra; A Di Palma; G Masera; S Terzoli; R Mauri
Journal:  Arch Dis Child       Date:  1982-02       Impact factor: 3.791

8.  Staging laparotomy and splenectomy: treatment and complications of Hodgkin's disease in children.

Authors:  P Lanzkowsky; A Shende; G Karayalcin; I Aral
Journal:  Am J Hematol       Date:  1976       Impact factor: 10.047

9.  Chelation studies with 2,3-dihydroxybenzoic acid in patients with beta-thalassaemia major.

Authors:  C M Peterson; J H Graziano; R W Grady; R L Jones; H V Vlassara; V C Canale; D R Miller; A Cerami
Journal:  Br J Haematol       Date:  1976-08       Impact factor: 6.998

Review 10.  Thalassemia major: molecular and clinical aspects. NIH Conference.

Authors: 
Journal:  Ann Intern Med       Date:  1979-12       Impact factor: 25.391
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.